glucuronic acid has been researched along with Prostatic Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dash, AK; Saralkar, P | 1 |
| Dong, Y; Du, Z; Huang, B; Tang, Y; Wang, W; Zhang, K; Zheng, X; Zhou, W | 1 |
| Aatonen, M; Af Hällström, TM; Kallioniemi, O; Laitinen, S; Mirtti, T; Nandania, J; Nordberg, ME; Puhka, M; Rannikko, A; Siljander, PR; Takatalo, M; Valkonen, S; Velagapudi, V; Yliperttula, M | 1 |
| Barbier, O; Bélanger, A; Caron, P; Fazli, L; Grosse, L; Pâquet, S; Rennie, PS | 1 |
| Florczyk, SJ; Kievit, FM; Stephen, ZR; Wang, K; Zhang, M | 1 |
| Kanaya, J; Koh, E; Namiki, M; Takashima, M | 1 |
| Dahut, WL; Figg, WD; Lakhani, NJ; Sparreboom, A; Veenstra, TD; Venitz, J; Xu, X | 1 |
1 trial(s) available for glucuronic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol.
Topics: 2-Methoxyestradiol; Administration, Oral; Antineoplastic Agents; Biotransformation; Chromatography, High Pressure Liquid; Drugs, Investigational; Estradiol; Female; Glucuronic Acid; Humans; In Vitro Techniques; Male; Microsomes, Liver; Molecular Structure; Ovarian Neoplasms; Oxidation-Reduction; Prostatic Neoplasms; Tandem Mass Spectrometry | 2007 |
6 other study(ies) available for glucuronic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Alginate Nanoparticles Containing Curcumin and Resveratrol: Preparation, Characterization, and In Vitro Evaluation Against DU145 Prostate Cancer Cell Line.
Topics: Alginates; Antineoplastic Agents; Cell Line, Tumor; Curcumin; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Humans; Male; Nanoparticles; Particle Size; Prostatic Neoplasms; Resveratrol; Stilbenes | 2017 |
Three-dimensional prostate tumor model based on a hyaluronic acid-alginate hydrogel for evaluation of anti-cancer drug efficacy.
Topics: Alginates; Antineoplastic Agents; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glucuronic Acid; Hexuronic Acids; Humans; Hyaluronic Acid; Male; Matrix Metalloproteinases; Prostatic Neoplasms | 2017 |
Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.
Topics: Adult; Chromatography, Liquid; Extracellular Vesicles; Glucuronic Acid; Humans; Male; Metabolomics; Microscopy, Electron; Prostatic Neoplasms; Ribosemonophosphates; Tandem Mass Spectrometry | 2017 |
Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.
Topics: Androgen Antagonists; Androgens; Antineoplastic Agents, Hormonal; Early Detection of Cancer; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucuronic Acid; Glucuronosyltransferase; Humans; Male; Minor Histocompatibility Antigens; Molecular Targeted Therapy; Prognosis; Prostatic Hyperplasia; Prostatic Neoplasms; Tumor Cells, Cultured | 2013 |
3D Porous Chitosan-Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer.
Topics: Alginates; Animals; Chitosan; Female; Genetic Therapy; Glucuronic Acid; Hexuronic Acids; Humans; In Vitro Techniques; Male; Mice; Nanoparticles; Porosity; Prostatic Neoplasms | 2015 |
Androgen-independent growth in LNCaP cell lines and steroid uridine diphosphate-glucuronosyltransferase expression.
Topics: Androgens; Cell Division; DNA, Antisense; Glucuronic Acid; Glucuronosyltransferase; Humans; Male; Prostatic Neoplasms; Transfection; Tumor Cells, Cultured | 2003 |